Refractory T Acute Lymphoblastic Leukemia
specificAn acute lymphoblastic leukemia that does not respond to treatment.
33
Centers
35
Active Trials
—
Cancer Funding
Top Centers for Refractory T Acute Lymphoblastic Leukemia(33)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | University of Illinois Cancer CenterChicago, IL High-Volume Research Center | 72.7 |
| 2 | Cancer Center at IllinoisUrbana, IL High-Volume Research Center | 72.7 |
| 3 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 50.2 |
| 4 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 50.2 |
| 5 | NCI Comprehensive Active Research Program | 50.2 |
| 6 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program | 50.2 |
| 7 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 50.2 |
| 8 | NCI Comprehensive Active Research Program | 50.2 |
| 9 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 50.2 |
| 10 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 50.2 |
| 11 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program | 50.2 |
| 12 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 50.2 |
| 13 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 50.2 |
| 14 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 50.2 |
| 15 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 50.2 |
| 16 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 50.2 |
| 17 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 50.2 |
| 18 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 50.2 |
| 19 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program | 50.2 |
| 20 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 50.2 |
| 21 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 50.2 |
| 22 | Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive Active Research Program | 50.2 |
| 23 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program | 50.2 |
| 24 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 50.2 |
| 25 | University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program | 50.2 |
| 26 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 50.2 |
| 27 | Active Research Program | 50.2 |
| 28 | Penn State Cancer InstituteHershey, PA Active Research Program | 50.2 |
| 29 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 50.2 |
| 30 | Livestrong Cancer InstitutesAustin, TX Active Research Program | 50.2 |
| 31 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 50.2 |
| 32 | Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program | 50.2 |
| 33 | Loma Linda University Cancer CenterLoma Linda, CA Active Research Program | 50.2 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →